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Introduction
Approximately 2.8 billion people use solid 
fuels (wood, animal dung, agricultural wastes, 
charcoal, and coal) for cooking and heating, 
a number little changed since 1980 (Bonjour 
et al. 2013; Rehfuess et al. 2006). Solid fuel 
combustion leads to high levels of health-
damaging household air pollution (HAP) 
including carbon monoxide (CO), particulate 
matter (PM), nitrogen dioxide (NO2), and 
polycyclic aromatic hydrocarbons (Naeher 
et al. 2007). Studies consistently show high 
HAP levels in households using solid fuels, 
with PM2.5 (≤ 2.5 μm) being observed to be 
10 to > 50 times the WHO annual average 
Air Quality Guideline level (WHO 2006). 
Women and young children especially expe-
rience high levels of HAP exposure because 
of traditional gender-based household roles 
involving more time in proximity to the stove 
(Torres-Duque et al. 2008).
Globally, HAP from solid fuel use was 
estimated by the Global Burden of Disease 
Project 2010 (GBD-2010) to account for 
3.5 million [95% (confidence interval (CI): 
2.7, 4.4 million] deaths and 4.3% (95% CI: 
3.4, 5.3) of disability-adjusted life years in 
2010 (Lim et al. 2012). Additionally it has 
been estimated that 16% of the 3.1 million 
deaths from outdoor air pollution are attribut-
able to HAP through its impact on ambient 
air (Lim et al. 2012). Accordingly, HAP is 
ranked fourth in terms of global burden when 
compared with 67 risk factors contributing 
to the Global Burden of Disease calculations 
(second among women) (Lim et al. 2012). 
This HAP-related mortality arises from four 
disease outcomes: chronic obstructive pulmo-
nary disease (COPD), acute lower respira-
tory infections (ALRI) in children < 5 years 
of age, and from cardiovascular disease and 
lung cancer (Smith et al. 2004, 2014). In 
addition, although there is a paucity of epide-
miological investigation, there is evidence of 
an association between HAP and other health 
outcomes including cataracts and adverse 
pregnancy outcomes (Pope et al. 2010; Smith 
et al. 2014).
Smith et al. (2014) estimated that 
HAP-related COPD resulted in almost 
800,000 premature deaths per year (Smith 
et al. 2014). Although cigarette smoking 
among women remains low in most devel-
oping countries, women exposed to HAP in 
such countries develop COPD with clinical 
characteristics, quality of life, and increased 
mortality similar in degree to that of tobacco 
smokers (Fullerton et al. 2008). Three 
published systematic reviews and meta- analyses 
of HAP and COPD have reported significant 
pooled effect estimates: odds ratio (OR) = 2.80 
(95% CI: 1.85, 4.00) (Kurmi et al. 2010), 
OR = 2.44 (95% CI: 1.90, 2.33) (Hu et al. 
2010), and OR = 2.40 (95% CI: 1.47, 3.93) 
(Po et al. 2011). Recently, a further meta-
analysis reported an increased pooled effect 
of biomass smoke exposure of OR = 1.94 
(95% CI: 1.62, 2.33)—an estimate used in 
the comparative risk assessment of HAP for 
GBD-2010 (Smith et al. 2014). With most 
studies included in the meta-analyses not 
directly measuring exposure, the effect esti-
mates were based on exposure determined by 
fuel type (e.g., “use of solid fuels” or “exposure 
to biomass” compared with “use of other 
fuels”). All meta-analyses identified a larger 
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Background: With 40% of the world’s population relying on solid fuel, household air  pollution 
(HAP) represents a major preventable risk factor for COPD (chronic obstructive pulmonary 
disease). Meta-analyses have confirmed this relationship; however, constituent studies are 
 observational, with virtually none measuring exposure directly.
oBjectives: We estimated associations between HAP exposure and respiratory symptoms and lung 
function in young, nonsmoking women in rural Guatemala, using measured carbon monoxide 
(CO) concentrations in exhaled breath and personal air to assess exposure.
Methods: The Randomized Exposure Study of Pollution Indoors and Respiratory Effects 
(RESPIRE) Guatemala study was a trial comparing respiratory outcomes among 504 women using 
improved chimney stoves versus traditional cookstoves. The present analysis included 456 women 
with data from postintervention surveys including interviews at 6, 12, and 18 months (respiratory 
symptoms) and spirometry and CO (ppm) in exhaled breath measurements. Personal CO was 
measured using passive diffusion tubes at variable times during the study. Associations between CO 
concentrations and respiratory health were estimated using random intercept regression models.
results: Respiratory symptoms (cough, phlegm, wheeze, or chest tightness) during the previous 
6 months were positively associated with breath CO measured at the same time of symptom 
reporting and with average personal CO concentrations during the follow-up period. CO in exhaled 
breath at the same time as spirometry was associated with lower lung function [average reduction 
in FEV1 (forced expiratory volume in 1 sec) for a 10% increase in CO was 3.33 mL (95% CI: 
–0.86, –5.81)]. Lung function measures were not significantly associated with average post-
intervention personal CO concentrations.
conclusions: Our results provide further support for the effects of HAP exposures on airway 
inflammation. Further longitudinal research modeling continuous exposure to particulate matter 
against lung function will help us understand more fully the impact of HAP on COPD.
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effect in women, the latter reporting a pooled 
OR of 2.30 (95% CI: 1.73, 2.06) in women 
compared with 1.90 (95% CI: 1.15, 3.13) in 
men, reflecting their greater exposure to HAP 
(Smith et al. 2014).
These systematic reviews highlighted the 
variability in study quality and considerable 
methodological and statistical heterogeneity 
(Hu et al. 2010; Kurmi et al. 2010; Po et al. 
2011). In addition, most studies used cross-
sectional or case–control designs (Hu et al. 
2010; Po et al. 2011; Smith et al. 2014), with 
only one retrospective cohort study (Kurmi 
et al. 2010) and no prospective cohort studies 
or intervention designs. Finally, only one 
study used a direct exposure measure (Liu 
et al. 2007), the rest using exposure proxies 
(fuel/stove type and time spent by fire) (Hu 
et al. 2010; Kurmi et al. 2010; Po et al. 
2011; Smith et al. 2014). Such proxies can 
lead to substantial exposure misclassifica-
tion. Accurate, direct measurement of HAP 
exposure is required to define exposure–
response relationships (Smith-Sivertsen 
et al. 2009).
A randomized controlled trial (RCT) 
of a chimney stove intervention in Mexico, 
ineligible for these systematic reviews due to 
outcome definition criteria, found a signifi-
cant reduction in respiratory symptoms 
and lung function decline when compared 
with use of open fire only among women 
(50%) adherent in using the intervention 
(Romieu et al. 2009). These women had an 
FEV1 (forced expiratory volume in 1 sec) 
rate decline of 31 mL/year compared with 
61 mL/year in open fire users (p = 0.012).
The first RCT to investigate the impact 
of reduced HAP from a chimney cook-
stove intervention (plancha) on ALRI in 
children and the respiratory health of their 
mothers was carried out in rural Guatemala 
(RESPIRE; Randomized Exposure Study of 
Pollution Indoors and Respiratory Effects) 
(Smith et al. 2011). Intention-to-treat analysis 
found reductions in the risk of respiratory 
symptoms. In addition, a relationship between 
symptoms and lung function was found at 
baseline (Díaz et al. 2007a; Smith-Sivertsen 
et al. 2009). No significant association with 
lung function [FEV1 and FEV1/FVC (forced 
vital capacity) ratio], however, was observed. 
Exposure levels, assessed using CO as a 
proxy for PM2.5, were significantly reduced 
in intervention compared to control (open 
fire) groups: 61.6%; p < 0.0001, although 
postintervention PM2.5 exposure remained 
high with exposure distributions between 
groups overlapping (Smith et al. 2011; 
Smith-Sivertsen et al. 2009). The RESPIRE 
study allows investigation of the relationship 
between respiratory outcomes (symptoms 
and lung function) and a continu ous measure 
of postintervention exposure rather than by 
intervention and control groups based on the 
intention-to-treat analysis. Such an analysis 
would provide further support for the effects 
of HAP exposure on airway  inflammation in 
this young population.
We present here analysis from the 
RESPIRE trial modeling HAP exposure 
as a continuous measure of CO with lung 
symptoms and function in young nonsmoking 
women exposed to high HAP levels since birth.
Methods
The methods for the adult component 
of the RESPIRE trial have been published 
(Smith-Sivertsen et al. 2009) and are briefly 
described below.
Study population. Women were recruited 
from 23 indigenous communities in the 
rural highlands of San Marcos in north-
west Guatemala. At the time of the study 
the population primarily spoke Mam and 
 illiteracy was common (Hallman et al. 2006).
The main household fuel is wood, typi-
cally burned indoors in a three-stone open 
fire. Average levels of particulate matter 
(PM10- and PM2.5-respirable particles; 
diameter ≤ 10 or ≤ 2.5 μm) in this setting 
have been measured to be 717 μg/m3 and 
528 μg/m3, respectively (Naeher et al. 2000). 
Women spend 5 hr/day on average in a room 
with a lit open fire (Engle et al. 1998). An 
additional, concentrated source of exposure is 
the temazcal (traditional sauna) typically taken 
one to several times per week and leading to 
very high levels of CO and PM (Thompson 
et al. 2004). Smoking is uncommon.
A rapid census survey of 5,365 households 
in this region found 770 houses with children 
< 4 months and/or a pregnant woman and 
using open fires eligible for RESPIRE. Of 
these, 534 were recruited to the study and, 
following baseline assessment, randomly 
assigned to an intervention (received the 
chimney stove) (Smith et al. 2011; Smith-
Sivertsen et al. 2009) or control group (open 
fire). A total of 504 women (mean age, 
27.7 years) agreed to participate and were 
recruited in two phases—phase 1 in October–
November 2002 (group A: 153 intervention 
and 147 control women) and phase 2 in 
April–May 2003 (group B: 106 intervention 
and 98 control women).
The study was carried out over 2 years 
(October 2002 through December 2004). 
Women were surveyed at baseline, before 
randomization, and every 6 months until 
12 months (group A) and 18 months 
(group B) after randomization to intervention 
and control groups (Figure 1). Questionnaires 
were administered at each survey by a trained 
bilingual interviewer. Information included 
age, height, weight, pregnancy status, 
smoking, respiratory symptoms, and days 
since the temazcal was last used. Household 
information included building construction/
layout, number of children, others smoking, 
and number of consumer goods possessed 
(radio, television, refrigerator, bicycle, motor-
cycle, and car) combined into an asset index. 
Lung function and breath CO were measured 
at the woman’s home after the interview, and 
personal 48-hr CO exposure (diffusion tubes) 
was assessed at different times (Figure 1).
Meteorological data collected over 
6 months at the study center in San Lorenzo 
included rainfall (millimeters per day) and 
average, minimum, and maximum tempera-
tures (degrees Celsius). These readings were 
taken for each survey round after completion 
of interviews. Household elevation was avail-
able from baseline GPS measurement.
Ethical approvals for studies involving 
human participants were obtained from 
University of California (Berkeley, CA, USA), 
Universidad del Valle (Guatemala City, 
Guatemala), the U.S. Centers for Disease 
Control and Prevention (Atlanta, GA, USA), 
the University of Liverpool (Liverpool, UK), 
and WHO (Geneva, Switzerland). Local, 
trained fieldworkers visited each recruited 
household and obtained oral informed 
consent from the study women.
Assessment of respiratory symptoms and 
lung function. Questionnaires recorded 
frequency and duration of respiratory 
symptoms including cough, phlegm, wheeze, 
and chest tightness experienced in the previous 
6 months. Cough and phlegm are the most 
recognized symptoms of airway inflamma-
tion, and their chronicity was assessed based 
on the duration of symptoms (> 3 months 
indicating chronic cough and/or phlegm). 
Questions were based on standardized 
instruments [Medical Research Council/
International Union Against Tuberculosis 
and Lung Disease and International Study of 
Asthma and Allergies in Childhood (ISAAC)] 
(Abramson et al. 1991; Bai et al. 1998; ISAAC 
1998; Torén et al. 1993), with modification 
and piloting to improve comprehension (Díaz 
et al. 2007b). Questionnaires were translated 
into Mam following Spanish translation, with 
independent back-translation. A more detailed 
description of content and development of the 
study questionnaire has been published (Díaz 
et al. 2007a, 2007b). For analysis, respira-
tory outcomes included a) presence of cough, 
phlegm, cough and/or phlegm, wheeze, and 
chest tightness; b) presence of any respiratory 
symptom; and c) presence of chronic cough 
(> 3 months duration), chronic phlegm, 
chronic cough, and/or chronic phlegm.
Lung function, without broncho dilator 
use (FEV1, FVC, and FEV1/FVC ratio), was 
measured with a Micro Medical Microloop 
turbine spirometer (Micro Medical Ltd., 
Rochester, UK), using American Thoracic 
Society (1995) guidelines. Quality assurance 
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was maintained through weekly calibration, 
extensive training, and supervision (Díaz et al. 
2007a). Regular assessments of interobserver 
repeatability were carried out with additional 
training if required (Díaz et al. 2007a).
Exposure assessment. The primary measure 
of personal HAP exposure was CO (Naeher 
et al. 2000). Two approaches to assessment 
were available for this analysis: CO ppm in 
exhaled breath and 48-hr mean CO ppm 
measured with passive diffusion tubes.
Measurements of CO breath were carried 
out immediately following spirometry using 
a MicroMedical Micro CO (Micro Medical 
Ltd.). Women performed three measure-
ments outside the home at each survey and 
the average of the two highest readings was 
recorded. Quality assurance was maintained 
through regular instrument comparison, field-
worker training, and supervision (Díaz et al. 
2007a). Exhaled CO monitors were calibrated 
against standard CO 49.8-ppm span gas every 
2–4 weeks during the study period (Díaz et al. 
2007a; Smith et al. 2010). Previous work 
carried out by Naeher et al. (2001) in the 
study region found that CO measurements 
using the passive diffusion tubes were a good 
proxy for PM2.5 in homes using open fires 
and plancha stoves with a strong correlation 
between the measures (r = 0.92 for kitchen 
measurements). In addition when the open 
fire and plancha data were pooled, a strong 
correlation between mother personal CO and 
child personal CO was observed (r = 0.85).
Average 48-hr CO ppm was measured 
using 1DL CO passive diffusion tubes 
(Gastec Corp., Japan). Quality assurance in 
tube reading and validation of the data has 
been reported (Smith et al. 2010, 2011). 
Tube measurement validation included a) an 
instrument precision substudy (comparing 50 
pairs of Gastec 1DL duplicate tube measures), 
b) an exchangeability substudy (comparing 
50 pairs of 1D and 1DL tube measures), and 
c) an external validation substudy [where 
both the 1D (n = 45) and 1DL (n = 232) 
tube types were collocated with a continuous 
electrochemical CO monitor in the house-
hold kitchens] (Smith et al. 2010). Exposure 
measurements using tubes were taken at 
baseline (before randomization) and three 
times postintervention until the study end, 
but did not coincide with the home visits for 
assessment of symptoms, lung function, and 
CO in breath (Figure 1). Additional measure-
ments were taken before baseline for group A 
(Figure 1). Only postintervention measure-
ments were used in the current analysis.
Women were asked to wear the CO tubes 
during the monitoring period; fieldworkers 
stressed the importance of keeping the tube 
on or near the woman at all times, requesting 
the tube be kept near their bed during sleeping 
(Smith et al. 2010). The women were asked 
to remove the tubes when using the tradi-
tional sauna (temazcal) because very high 
levels of CO from this exposure saturate the 
tube reagent. For CO breath, the relatively 
short half-life of around 5 hr (Crowley et al. 
1989) and the varying timing of measure-
ments relative to recent exposure events of 
varying intensity at successive surveys will have 
added further within-person random error. 
In a study of individual and group variability 
in exposure assessment for children in the 
RESPIRE trial, child 48-hr CO was found to 
have a low reliability for measuring predicted 
long-term CO exposure through mixed 
modeling (intraclass correlation coefficient 
r = 0.33) (McCracken et al. 2009).
Statistical analysis. Analysis of exposure 
in exhaled CO used individual postinterven-
tion round measurements because these took 
place at the same time as the survey interviews 
and spirometry. Analysis of exposure by CO 
tubes used the mean of all postinterven-
tion measurements for each woman because 
measurements were not synchronized with 
home visits for health outcomes (Figure 1). 
Natural log (ln) transformation of data from 
both CO measures was used due to marked 
positive skew (Figure 2A,B).
The relationship between CO measures 
was assessed by correlation, using Spearman’s 
rho for untransformed data and Pearson 
correlation for log-transformed values. For this 
analysis, we estimated correlations between 
each CO tube measurement and the breath 
CO measurement at the next follow-up visit.
We examined the relationship between 
survey round measurements [ln(CO) exhaled 
breath] and average postintervention exposure 
[ln(CO) tube] with lung symptoms experi-
enced in the 6 months preceding each survey 
using random intercept logistic regression; (xt 
logit in Stata; StataCorp, College Station, TX, 
USA). The presence or absence of symptoms 
during the 6 months before the interview 
was recorded for each successive survey for 
repeated measures analysis over the three 
follow-up periods. Symptoms were defined as 
chronic if women reported having them for 
> 3 months. 
Because CO in exhaled breath was 
measured at the same time as spirometry was 
taken, we examined the relationship between 
the actual survey round measurements 
(lnCO ppm) with lung function (FEV1, FVC, 
and FEV1:FVC ratio–percentage) as a cross-
sectional analysis. For CO measured by the 
tubes, we modeled average postintervention 
exposure (lnCO ppm) with lung function. All 
analysis was conducted using random intercept 
linear regression (xt reg in Stata).
Confounding covariates were dealt with 
in two ways. First, factors that were fixed over 
time or estimated only once over the study 
were dealt with as non-time-varying  covariates 
[women’s age, height, weight, asset index 
(McCracken et al. 2009), altitude, and envi-
ronmental tobacco smoke exposure]. None of 
the women smoked. Second, factors that varied 
over time and were re-assessed at each succes-
sive survey were dealt with as time-varying 
Figure 1. Timing of assessment of personal exposure using CO tubes and of symptoms, lung function, 
and CO breath, in relation to the installation of the chimney stove, for recruitment groups A and B. 
Abbreviations: B, baseline; PI, postintervention; Q1–Q4, yearly quarters (3-month intervals). Number of CO 
tubes is listed (1–5). 
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covariates by including the survey-specific 
values. These included a) pregnancy status; 
b) season [dry and cold (November–February), 
dry and warm (March–April), wet (May–
October)]; c) rainfall (millimeters/24 hr); 
d) day of the week (to account for market 
days); e) daily minimum, maximum, and 
average temperatures (degrees Celsius); 
f) fieldworker (based on the code for the 
fieldworker carrying out the interview/
spirometry); g) recruitment group (coded as A 
or B; Figure 1); and h) days since last temazcal 
use (this was included as a covariate for CO 
tube modeling but not for CO breath which 
incorporates exposure to all recent combus-
tion sources). The covariates were included 
in multi variable models for adjustment if 
they modified effect estimates for associations 
between the exposure variables (CO breath 
and tube) and the outcome variables (respira-
tory symptoms and lung function) by at least 
5%. For models of lung function, age and 
height were automatically included.
Results
Table 1 shows the number of women providing 
exposure measurements (CO in exhaled 
breath and CO measured by tube) at each 
postintervention survey round by recruitment 
group. In addition, the total number of repeat 
measurements available for analysis of each 
CO indicator is shown. For CO measured in 
breath, > 90% of women provided at least one 
measurement for both recruitment groups. 
For CO measured by tube, 93% of women 
in group A and 88% of women in group B 
provided at least one exposure measurement. 
The average/median number of repeat measures 
was two for CO tubes (for both group A and 
group B) and two and three for CO breath for 
groups A and B, respectively. The correlations 
between CO breath and CO tube measure-
ments taken before each survey were low 
(Table 2) with r values ranging from 0.17 to 
0.36. The correlation between average post-
intervention CO breath and CO tube was low 
(Spearman’s rho = 0.33; p < 0.001).
Table 3 shows odds ratios for associa-
tions between ln-transformed breath CO at 
individual visits and symptoms during the 
previous 6 months, and ORs for associations 
between symptoms during each 6-month 
period and the ln-transformed average of all 
postintervention personal CO measurements. 
CO breath was positively associated with 
phlegm, chronic phlegm (> 3 months), cough 
and phlegm, chronic cough and chronic 
phlegm (> 3 months), wheezing, and chest 
tightness, although only univariate associa-
tions with wheeze and chronic phlegm were 
statistically significant (p < 0.05).
For CO tube measurements, there was 
a positive association with most respira-
tory symptoms, with the presence of any 
respiratory symptom (adjusted OR = 1.35; 
95% CI: 1.01, 1.81), phlegm (unadjusted 
OR = 1.51; 95% CI: 1.01, 2.27), combi-
nation of cough and phlegm (adjusted 
OR = 1.63; 95% CI: 1.00, 2.66), and wheeze 
(adjusted OR = 1.57; 95% CI: 1.07, 2.30) 
achieving statistical significance.
For lung function (Table 4), only exhaled 
CO showed an association, specifically with 
FEV1, with an adjusted value of –35 mL 
(95% CI: –9, –61) associated with each 
unit increase in ln-transformed CO breath 
(adjusted p = 0.008).
Discussion
To our knowledge, this is the first study to 
examine relationships between a continuous 
measure of HAP (albeit a proxy for exposure 
measured by CO) and prevalence of respira-
tory symptoms and lung function in young, 
nonsmoking women in a rural biomass fuel–
dependent population. Our results found 
exposure to CO (parts per million in exhaled 
breath and passive diffusion tubes) associ-
ated with common respiratory symptoms, 
particularly phlegm (tubes), cough and 
phlegm (tubes), and wheeze (exhaled breath 
Figure 2. Average postintervention CO tube (untransformed and ln transformed) (A). CO exhaled breath at 
12-month follow-up (untransformed and ln transformed) (B).
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Table 1. Number (%) of exposure measurements available for women postintervention, for CO tube and 
CO breath by recruitment group and survey round.
CO tube CO breath
Group A (n = 300) Group B (n = 204) Group A (n = 300) Group B (n = 204)
6-month survey 270 (90.0) 65 (31.9) 271 (90.3) 185 (90.7)
12-month survey 196 (65.3) 152 (74.5) 257 (85.7) 181 (88.7)
18-month survey — 170 (83.3) — 176 (86.3)
No. of measurements
0 22 (7.3) 24 (11.8) 25 (8.3) 14 (6.9)
1 90 (30.0) 22 (10.8) 22 (7.3) 9 (4.4)
2 188 (62.7) 109 (53.4) 253 (84.3) 10 (4.9)
3 — 49 (24.0) — 171 (83.8)
Table 2. Pearson correlation of CO tube and CO breath at each postintervention follow-up round (based 
on ln-transformed values).
Survey round
Recruitment group A Recruitment group B
Coefficient p-Value Coefficient p-Value
6 months 0.23 0.0002 0.36 0.005
12 months 0.18 0.015 0.17 0.042
18 months — — 0.32 < 0.0005
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and tubes). Although based on relatively 
small numbers, more chronic symptoms 
(> 3 months) appeared to have a larger 
positive association with CO. In addition, CO 
in exhaled breath was significantly associated 
with lower lung function measured at the 
same time after adjusting for covariates; the 
average reduction in FEV1 for a 10% increase 
in CO was 3.33 mL (95% CI: –0.86, –5.81).
The average (± SD) breath CO ppm levels 
in this study were 6.91 ± 3.33, 6.59 ± 2.97, 
and 6.90 ± 3.42 at 6, 12, and 18 months, 
respectively. A study of healthy smokers, 
passive smokers, and nonsmokers found 
average levels of CO ppm of 17.13 ± 8.50, 
5.20 ± 3.38, and 3.61 ± 2.15, respectively 
(Deveci et al. 2004). The levels observed in 
these relatively young nonsmoking women 
therefore fall between those for active and 
passive smokers and are greater than the 
published WHO 24-hr air quality guideline 
for CO of 6 ppm (WHO 2010). Although 
cigarette smoking is the leading cause of 
COPD in the developed world, HAP 
exposure is likely to be an important prevent-
able cause in lower- and middle-income 
countries, especially in women (Salvi and 
Barnes 2010).
The global health impact of HAP-related 
COPD is large, with GBD-2010 estimating 
that HAP accounted for 783,000 COPD 
deaths in 2010 (Smith et al 2014). Although 
there is strong quantitative evidence for an 
increased risk of COPD from HAP (Hu et al. 
2010; Po et al. 2011; Smith et al. 2014), this 
is largely based on observational data (typi-
cally cross-sectional and case–control studies). 
Increased exposure to biomass combustion has 
been associated with reduced lung function 
in cross-sectional studies of populations from 
Brazil (da Silva et al. 2012), Malawi (Fullerton 
et al. 2011), and Nepal (Pandey et al. 1985). 
Our findings provide evidence that may be 
used to better quantify the respiratory health 
effects of exposure to HAP.
The strengths of this study are the ability 
to compare directly measured exposure to 
a pollutant designated a good proxy for 
particulate matter (rather than other weaker 
proxies such as self-reported fuel use or time 
spent cooking) with objectively assessed 
lung function measured using standardized 
spirometry with repeated assessments of 
exposures and outcomes over 18 months. In 
addition, information on a range of covariates 
(both constant and time varying) was avail-
able for multivariable modelling of adjusted 
associations. (Smith et al. 2011).
There did not appear to be a consistent 
pattern in the relationship between the two 
measures of CO with respiratory symptoms 
and lung function. For CO tubes (averaged 
over the three postintervention periods), there 
was no association with lung function (reduced 
FEV1); however, for CO breath (analyzed for 
each of the three postintervention periods), 
exposure was significantly associated with a 
lower FEV1.
In our relatively young, nonsmoking 
female population, there were no COPD 
cases according to Global Initiative for 
Chronic Obstructive Lung Disease criteria 
(FEV1:FVC < 70) (Lenfant and Khaltaev 
2005). Typically HAP-associated COPD is 
seen in elderly women born in rural areas with 
lifelong HAP exposure from solid fuel use 
(Perez-Padilla et al. 2010). Although we did 
not observe an association between repeated 
Table 3. Results of random intercept logistic regression for effect of exposure (CO breath, round 
measurements; and CO tubes, postintervention average values) on respiratory symptoms: all post-
intervention survey rounds.
Symptoms
CO breath (n = 465; at least one measurement) CO tube (n = 458; at least one measurement)
No.a ORb (95% CI) p-Value No.a ORb (95% CI) p-Value
Symptom experienced in the last 6 months
Cough 114 (141) 106 (131)
Unadjusted 1.01 (0.46, 2.20) 0.98 1.22 (0.88, 1.70) 0.23
Adjustedc 0.96 (0.44, 2.10) 0.91 1.15 (0.82, 1.61) 0.41
Age Age, temazcal
Phlegm 68 (83) 63 (78)
Unadjusted 1.82 (0.72, 4.60) 0.21 1.51 (1.01, 2.27) 0.05
Adjustedc 1.57 (0.61, 4.06) 0.35 1.47 (0.98, 2.21) 0.06
Age, fieldworker, group, asset,d 
altitude, weight
Age
Cough or phlegm 135 (169) 126 (158)
Unadjusted 0.95 (0.45, 2.01) 0.90 1.24 (0.91, 1.69) 0.17
Adjustedc 0.88 (0.42, 1.86) 0.75 1.20 (0.88, 1.65) 0.25
Age Age, fieldworker, group
Cough and phlegm 46 (55) 42 (49)
Unadjusted 2.62 (0.90, 7.63) 0.08 1.67 (1.03, 2.72) 0.04
Adjustedc 2.32 (0.73, 7.40) 0.15 1.63 (1.00, 2.66) 0.05
Age, fieldworker, group, asset,d 
rainfall, height, weight, pregnancy
Age
Wheeze 67 (78) 62 (72)
Unadjusted 2.65 (1.12, 6.26) 0.03 1.64 (1.12, 2.39 0.01
Adjustedc 2.28 (0.94, 5.52) 0.07 1.57 (1.07, 2.30) 0.02
Age, fieldworker, asset,d altitude, 
max temp, weight
Age
Chest tightness 82 (101) 75 (94)
Unadjusted 2.20 (0.92, 5.25) 0.08 1.38 (0.95, 2.01) 0.09
Adjustedc 1.71 (0.69, 4.23) 0.25 1.31 (0.90, 1.91) 0.16
Age, fieldworker, altitude, weight, 
temazcal
Age
Any symptom 184 (250) 170 (232)
Unadjusted 1.32 (0.67, 2.62) 0.42 1.40 (1.04, 1.88) 0.03
Adjustedc 1.16 (0.57, 2.34) 0.68 1.35 (1.01. 1.81) 0.04
Age, fieldworker, ETS Age
Symptom experienced in the last 6 months for > 3 months
Cough 57 (78) 53 (73)
Unadjusted 1.45 (0.61, 3.50) 0.40 1.19 (0.84, 1.68) 0.34
Adjustedc 1.11 (0.46, 2.67) 0.82 1.21 (0.85, 1.74) 0.29
Age, height, weight, ETS, season, 
rainfall, min temp
Age, fieldworker, group
Phlegm 36 (42) 34 (40)
Unadjusted 3.28 (1.02, 10.54) 0.05 1.37 (0.82, 2.29) 0.23
Adjustedc 2.56 (0.83, 7.93) 0.10 1.31 (0.77, 2.22) 0.32
Age, asset,d altitude, height, weight Age, fieldworker, group, height
Cough or phlegm 73 (85) 69 (80)
Unadjusted 1.56 (0.67, 3.62)  0.30 1.19 (0.83, 1.69) 0.34
Adjustedc 1.29 (0.54, 3.09)  0.57 1.21 (0.83, 1.76) 0.32
Age, fieldworker, height, ETS Age, fieldworker, group, height
Cough and phlegm 23 (26) 21 (24)
Unadjusted 3.15 (0.87, 11.42) 0.08 1.58 (0.87, 2.89) 0.13
Adjustedc 2.66 (0.66, 10.79) 0.17 1.59 (0.84, 3.01) 0.15
Age, asset,d height, weight, rainfall, 
pregnancy
Age, height, weight, pregnancy
ETS, environmental tobacco smoke.
aNumber of women with exposure data reporting a symptom on at least one occasion (number in parentheses is the 
total number of times the symptom was reported post intervention). bOdds ratio for a 1-unit increase in CO exposure (ln 
transformed), all adjusted for nonindependency of data for repeated measures within individuals. cCovariates included 
in adjusted model are indicated for each analysis. dAsset index is based on number of consumer goods possessed 
(radio, television, refrigerator, bicycle, motorcycle, and car). 
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measures of 48-hr personal exposure to CO (as 
a proxy for PM) and repeated lung function 
measurements, we did find significant asso-
ciations with acute and chronic respiratory 
symptoms, albeit based on small numbers for 
the latter. In addition, we observed a signifi-
cant association between CO in exhaled breath 
(a proxy for more recent exposure) and lower 
FEV1 measured at the same time. Further 
follow-up of the study women would be 
needed to fully understand this relationship.
CO as an indicator for health-damaging 
constituents of HAP. CO was used to repre-
sent HAP exposure because it was practical 
to measure lung function using passive diffu-
sion tubes and in exhaled breath (at the same 
time spirometry was carried out). A wide range 
of pollutants will contribute to respiratory 
symptoms and lung function deficit leading 
to COPD, particularly respirable particulate 
matter (Ling and van Eeden 2009). Although 
CO has been demonstrated cross-sectionally to 
be a reliable proxy for PM2.5 in kitchens where 
biomass is the primary fuel, little is known 
about this relationship for personal exposure 
(McCracken et al. 2013). The RESPIRE study 
quantified the relationship within this study 
population. Repeated measures (216 measures) 
of 24-hr PM2.5 and CO ppm (passive diffusion 
tubes) in 116 women found CO explained 
78% of between-subject variance in personal 
PM2.5, suggesting that CO is a reliable surro-
gate for individual’s exposure to respirable 
particulates (McCracken et al. 2013).
Mechanisms. It is likely that HAP exposure 
causes an inflammatory response and increased 
oxidative stress in the respiratory tract, particu-
larly in lower airways (Barregard et al. 2006, 
2008; Swiston et al. 2008). Evidence from 
animal models involving rats suggest biomass 
smoke exposure from cow dung and wood can 
lead to chronic bronchitis, bronchiolitis, and 
peribronchial fibrosis (Hu et al. 2013; Rai et al. 
1982). Research summarizing the potential 
adverse health effects of individual constitu-
ents of air pollution from woodsmoke iden-
tified exposure to nitrogen dioxide as being 
associated with toxicological effects including 
pulmonary edema, broncho constriction, 
and increased respiratory infection rates; and 
exposure to particulate matter as a) being 
associated with decreased lung function in 
children and b) having mutagenic properties 
within the lower respiratory tract (Pierson 
et al. 1989). In a controlled experiment 
where 20 healthy individuals were exposed 
to woodsmoke combustion with PM2.5 levels 
ranging from 165 to 303 μg/m3 and 205 
to 662 μg/m3 for low and high exposure, 
respectively, significant mucosal irritation 
was detected, assessed using a standardized 
self-reported rating scale of irritation of the 
throat, nose, and eyes (Riddervold et al. 2011). 
Acute exposure to particulate matter from 
ambient air pollution episodes has been found 
to be associated with reduced lung function 
in children in the United States and the 
Netherlands, with declines in lung function 
associated with episodic exposure to suspended 
particles occurring rapidly and persisting 
for up to 3 weeks before recovery (Pierson 
et al. 1989). In a U.S. study of exposure to 
ambient particulate matter and respiratory 
effects in asthmatic children, levoglucosan (a 
marker of woodsmoke) was measured outside 
and was found to be significantly associated 
with a decrease in measured lung function 
(FEV1) (Allen et al. 2008). In a sample of 
45 women from the RESPIRE population, 
we found exposure to indoor biomass smoke 
to be associated with higher gene expression 
of multiple mediators of airway inflammation 
and remodeling. These mechanisms could 
explain some of the observed association 
between prolonged biomass smoke exposure 
and COPD (Guarnieri et al. 2014). In a 
study comparing COPD patients exposed to 
woodsmoke and tobacco smoke with controls 
for matrix metalloproteinase (MMP) activity 
and expression, researchers found significant 
increases in MMP-2 and MMP-9 in both 
exposed groups and concluded that such 
increased activity from wood smoke exposure 
could produce lung damage similar to COPD 
associated with tobacco smoke (Montaño 
et al. 2004). In addition, an imbalance of 
oxidants/antioxidants caused by pollutants 
such as those derived from biomass combus-
tion could play a role in COPD pathogenesis 
by regulating redox-sensitive transcription 
factors (e.g., nuclear factor κB), autophagy, 
and unfolded protein response leading to 
chronic lung inflammatory response (Yao and 
Rahman 2011). CO has been implicated as 
a possible indicator of lung and/or systemic 
inflammation, and breath CO has been widely 
studied as a putative inflammatory marker of 
disease in relation to asthma, COPD, cystic 
fibrosis, bronchiectasis, and systemic condi-
tions (sepsis and diabetes) (Ryter and Choi 
2013). Our study identified an increased risk 
of common and chronic respiratory symptoms 
with higher CO exposure measured by tube 
and in breath (although the majority only 
reached statistical significance for the former), 
consistent with acute mucosal irritation and 
 inflammatory response. 
There are a number of limitations in 
the current study that should be considered 
when interpreting the findings. First, given 
the observational nature of the analysis 
(despite being part of a randomized trial), 
there is likely to be some confounding. We 
attempted to account for this by adjusting 
for a variety of covariates collected as part of 
the trial; however, there is the potential for 
residual confounding or confounding where 
the covariates were not adequately controlled. 
Second, there might be some differential 
misclassification between women who received 
the intervention (less exposed) and those who 
were controls in terms of the self-reporting 
of respiratory symptoms. Finally, for some 
of the respiratory outcomes confidence inter-
vals were wide, reflecting low precision due to 
small numbers of women reporting symptoms 
(particularly those that were chronic).
Conclusion
RESPIRE Guatemala (the first RCT studying 
the effect of HAP on health) has allowed 
examination of relationships between directly 
Table 4. Results of random-effects linear regression for effect of exposure [CO breath, all postintervention 
survey rounds (maximum n = 3 per woman); CO tube, postintervention average] on lung function.
Measure of lung 
function
CO breath (n = 465)a (round values) CO tube (n = 458)a (postintervention average)
Coefficientb (95% CI) p-Value Coefficientb (95% CI) p-Value
FEV1 (L)
Unadjusted –0.031 (–0.056, –0.006) 0.02 0.012 (–0.030, 0.053) 0.58
Adjustedc –0.035 (–0.061, –0.009) 0.01 0.015 (–0.019, 0.050) 0.39
Age, fieldworker, group, asset,d weight, 
altitude, season, minimum temperature, 
day of week
Age, height, group, asset,d weight, altitude, season, 
minimum temperature, day of week, temazcal
FVC (L)
Unadjusted –0.024 (–0.055, 0.007) 0.13 0.027 (–0.021, 0.075) 0.27
Adjustedc –0.026 (–0.057, 0.006) 0.11 0.028 (–0.010, 0.064) 0.14
Age, weight, altitude, season, minimum 
temperature, day of week
Age, height, group, asset,d weight, altitude, season, 
rainfall, minimum temperature, day of week
FEV1:FVC ratio (%)
Unadjusted –0.401 (–0.963, 0.162) 0.16 –0.319 (–0.853, 0.215) 0.24
Adjustedc –0.356 (–0.932, 0.221) 0.23 –0.272 (–0.823, 0.268) 0.32
Age, height, fieldworker, weight, altitude, 
season, minimum temperature, day of 
week
Age, height, group, asset,d weight, altitude, 
season, rainfall, minimum temperature, day of 
week, temazcal
aOf the 465 women providing at least one CO breath measurement, 458 (98%) provided measurements from spirometry. 
Of the 458 providing at least one CO tube measurement, 431 (94%) provided measurements from spirometry. bBeta 
coefficient represents the difference in lung function in litres associated with a 1-unit increase in CO (ln transformed), 
all adjusted for time. cCovariates are included in adjusted model indicated for each analysis. dAsset index is based on 
number of consumer goods possessed (radio, television, refrigerator, bicycle, motorcycle, and car).
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measured personal HAP exposure (CO ppm) 
and risk of respiratory symptoms and levels 
of lung function in young, nonsmoking 
women—evidence previously missing from 
the literature. Common respiratory symptoms 
(including cough, phlegm, wheeze, and chest 
tightness) were increased in association with 
CO concentrations measured in exhaled 
breath and by passive diffusion tube. Chronic 
symptoms (> 3 months) were also associated, 
although based on a small number of obser-
vations. In addition, CO in exhaled breath 
was significantly associated with lower lung 
function at the same time, after adjusting for 
covariates with an average reduction in FEV1 
for a 10% increase in CO of 3.33 mL (95% CI: 
–0.86, –5.81). Given the limitations of our 
study in relation to the potential for uncon-
trolled confounding, misclassification, and 
random error, confirmation of these findings 
requires further prospective studies to examine 
changes in COPD incidence following inter-
ventions to decrease HAP exposure from solid 
fuel use, and will require larger sample sizes 
and/or duration of follow-up.
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